Tugtepe H, Thomas D T, Ergun R, Kalyoncu A, Kaynak A, Kastarli C, Dagli T E
Marmara University School of Medicine, Department of Pediatric Surgery, Division of Pediatric Urology, Istanbul, Turkey.
Pendik State Hospital, Department of Pediatric Surgery, Istanbul, Turkey.
J Pediatr Urol. 2015 Jun;11(3):137.e1-5. doi: 10.1016/j.jpurol.2014.10.016. Epub 2015 Mar 12.
While there are many options for children with treatment refractory urinary incontinence, there is no single accepted method. This study's aim was to prospectively evaluate the effect of transcutaneous electrical nerve stimulation in children with urinary incontinence resistant to standard medical, urological therapy and/or biofeedback.
PATIENTS & METHODS: This study was performed at a university hospital. For inclusion, patients >5 years of age first underwent evaluation with urinary ultrasonography, uroflow-electromyogram and voiding diaries. Treatment with biofeedback, alpha adrenergic blockers, anticholinergics and/or urotherapy was commenced according to uroflow-EMG and voiding diary findings. Patients with partial or no response to this standard therapy were then included in this study, performed between April 2012 and February 2014. Patients with anatomical or neurological causes for urinary incontinence were excluded. TENS was performed on S3 dermatome, every day for 3 months. Each session lasted 20 min with a frequency of 10 Hz and generated pulse of 350 μs. Intensity was determined by the child's sensitivity threshold. Medical treatment and urological therapy was continued during TENS. Uroflow parameters (voiding volume as percentage of expected bladder capacity, Qmax, Qave, flow and voiding time, postvoiding residual urine) and urinary system symptoms (presence of urinary tract infection, frequency, urge incontinence, fractionated voiding and constipation) were compared immediately before commencement and immediately after the completion of 3 months of TENS.
Twenty-seven patients were included in this study (4 males, 23 females). Patients' average age was 7.2 years, 11 had overactive bladder and 16 had dysfunctional voiding. Comparison of urinary system symptoms and uroflow parameters before and after TENS are shown in Table. After 3 months of TENS; a statistically significant decrease was observed in the number of patients with frequency, urge incontinence, urinary tract infections and constipation. There was a decrease in the number of patients with fractionated voiding, although this change was not statistically significant. Similarly, for uroflow-EMG parameters; bladder capacity, Qmax, Qave and flow time increased while voiding time and PVR decreased. Changes seen in bladder capacity, Qmax and PVR were statically significant, while other changes were not. Patients' response rates after 3 months of TENS were; complete response in 70.4%, partial response in 22.2% and no response in 7.4%.
This study has shown that transcutaneous electrical nerve stimulation is a promising treatment option for standard-treatment refractory children with urinary incontinence.
虽然对于治疗难治性尿失禁的儿童有多种选择,但尚无一种被普遍接受的方法。本研究的目的是前瞻性评估经皮电神经刺激对经标准药物、泌尿外科治疗和/或生物反馈治疗无效的尿失禁儿童的疗效。
本研究在一家大学医院进行。纳入标准为年龄大于5岁的患者,首先接受尿液超声、尿流-肌电图和排尿日记评估。根据尿流-肌电图和排尿日记结果开始进行生物反馈、α肾上腺素能阻滞剂、抗胆碱能药物和/或尿疗法治疗。对这种标准治疗部分或无反应的患者随后纳入本研究,研究于2012年4月至2014年2月进行。排除因解剖或神经原因导致尿失禁的患者。在S3皮节进行经皮电神经刺激,每天一次,持续3个月。每次治疗持续20分钟,频率为10Hz,脉冲宽度为350μs。强度由儿童的敏感阈值确定。在经皮电神经刺激期间继续进行药物治疗和泌尿外科治疗。比较经皮电神经刺激开始前和3个月治疗结束后立即测量的尿流参数(排尿量占预期膀胱容量的百分比、最大尿流率、平均尿流率、尿流时间和排尿时间、残余尿量)和泌尿系统症状(是否存在尿路感染、尿频、急迫性尿失禁、分次排尿和便秘)。
本研究纳入27例患者(4例男性,23例女性)。患者平均年龄为7.2岁,11例患有膀胱过度活动症,16例存在排尿功能障碍。经皮电神经刺激前后泌尿系统症状和尿流参数的比较见表。经皮电神经刺激3个月后;尿频、急迫性尿失禁、尿路感染和便秘患者数量有统计学意义的下降。分次排尿患者数量有所减少,尽管这一变化无统计学意义。同样,对于尿流-肌电图参数;膀胱容量、最大尿流率、平均尿流率和尿流时间增加,而排尿时间和残余尿量减少。膀胱容量、最大尿流率和残余尿量的变化具有统计学意义,而其他变化无统计学意义。经皮电神经刺激3个月后患者的反应率为;完全缓解70.4%,部分缓解22.2%,无缓解7.4%。
本研究表明,经皮电神经刺激对于标准治疗难治性尿失禁儿童是一种有前景的治疗选择。